The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers

OncoImmunology - Tập 4 Số 6 - Trang e1009285 - 2015
Hideki Ujiie1, Kyuichi Kadota2, Jun‐ichi Nitadori3, Joachim G.J.V. Aerts4, Kaitlin M. Woo5, Camelia S. Sima5, William D. Travis6, David R. Jones3, Lee M. Krug7, Prasad S. Adusumilli8
1Thoracic Service; Department of Surgery; Memorial Sloan Kettering Cancer Center ; New York, NY, USA ; Department of Clinical Molecular Biology; Graduate School of Medicine; Chiba University ; Chiba, Japan.
2Thoracic Service; Department of Surgery; Memorial Sloan Kettering Cancer Center ; New York, NY, USA ; Department of Pathology; Memorial Sloan Kettering Cancer Center ; New York, NY, USA.
3Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
4Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
5Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
6Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
7Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
8Thoracic Service; Department of Surgery; Memorial Sloan Kettering Cancer Center ; New York, NY, USA ; Center of Cell Engineering; Memorial Sloan Kettering Cancer Center ; New York, NY, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(05)67025-0

10.1200/JCO.2008.20.3943

10.1097/01243894-200605000-00004

10.1016/j.jtcvs.2007.10.026

10.1007/s00262-010-0881-6

10.1183/09031936.06.00135305

10.1126/scitranslmed.3010162

10.1126/scitranslmed.3006941

10.1097/JTO.0b013e31822a3740

10.1126/science.1129139

10.1007/s00262-011-1103-6

10.1056/NEJMoa051424

10.1056/NEJMoa020177

10.1200/JCO.2010.30.5037

10.1007/s00262-011-1073-8

10.1073/pnas.0709205105

10.1182/blood-2003-07-2379

10.1126/science.2118273

10.1016/j.ccr.2005.04.014

10.1007/s10549-011-1620-1

10.1158/1078-0432.CCR-08-0133

10.1371/journal.pone.0006412

10.1186/1471-2407-13-436

Lissbrant IF, 2000, Int J Oncol, 17, 445

10.1189/jlb.0609385

10.1002/path.1027

10.1016/j.semcancer.2008.03.004

10.1093/jnci/djs235

Izzi V, 2009, Int J Oncol, 34, 543

10.4049/jimmunol.175.3.1483

10.1016/j.yexcr.2012.09.006

10.1200/JCO.2012.45.2052

10.4161/onci.24036

10.1016/j.ejca.2008.12.006

10.1002/bjs.4832

10.1038/nri2580

10.1038/modpathol.2012.58

10.1097/JTO.0b013e318211127a

10.1158/1078-0432.CCR-11-2614

10.1097/JTO.0b013e31815608d9

Edge SB, 2010, AJCC cancer staging manual

10.1158/1078-0432.CCR-13-1862

10.1158/1078-0432.CCR-09-0986

10.1002/(SICI)1097-0258(20000115)19:1%3c113::AID-SIM245%3e3.0.CO;2-O